Autonomix Medical, Inc..
AMIX.US | Manufacture of medical and dental instruments and supplies
Autonomix Medical, Inc. is a medical device company focused on developing innovative solutions for improving surgical outcomes and patient care. The company's primary focus is on developing and commercializing minimally invasive surgical tools and technologies that target the autonomic nervous syste...Show More
Better Health for All
0
Autonomix Medical's core business is developing innovative medical devices for pain management, particularly for severe conditions like pancreatic cancer. Its first-in-human study (PoC 1) demonstrated significant pain reduction, with a mean 5.08 reduction on the VAS pain scale (66% improvement) and 100% of responding patients becoming opioid-free at 3 months post-procedure, along with improved quality of life.
1
The company's entire product portfolio is devoted to health improvement. The PoC 1 study reported one procedural-related serious adverse event (hematoma requiring hospitalization) in a separate clinical population of three subjects, and 14 adverse events (including 8 expected arterial constrictions).
2
Additionally, 8 serious adverse events unrelated to the device or procedure occurred, including 6 patient deaths due to disease progression.
3
The company's initial trials focus on pancreatic cancer patients with a life expectancy of 3 months or more, and it is expanding to a broader range of visceral cancers, but there is no evidence of specific programs to reach low-income or marginalized populations.
4
The company has invested in developing a novel, minimally invasive nerve ablation platform, holding over 120 issued or pending patents.
5
Its technology may offer 3,000 times greater sensitivity than existing technologies.
6
The company has received Ethics Committee authorization from the Ministry of Health of the Republic of Uzbekistan for its follow-on clinical trial (PoC 2) and plans to submit for FDA investigational device exemption (IDE) for U.S. trials in 2025/2026.
7
The company discloses that its technology is investigational and not yet cleared for marketing.
8
Fair Money & Economic Opportunity
0
Autonomix Medical, Inc. is a medical device company focused on developing surgical tools and technologies. The provided articles detail its patent grants and clinical trials for medical devices. There is no evidence in the articles that the company offers any financial services, lending, insurance, or deposit services to consumers. Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are not applicable to Autonomix Medical, Inc.'s core business activities.
Fair Pay & Worker Respect
0
Autonomix Medical, Inc. has no documented regulatory actions, violations, or fines related to labor.
1
The CEO's employment agreement details a base salary of $450,000 and a target annual bonus of $270,000, along with a stock option grant of 900,000 shares.
2
The agreement also includes COBRA health insurance continuation for 12 to 18 months under specific severance conditions.
3
No other quantitative data is available for assessment against the remaining KPIs.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Autonomix Medical, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete evidence was found in the provided article for any of the KPIs related to Honest & Fair Business. The article mentions a Nasdaq deficiency letter regarding the company's common stock closing below the minimum $1.00 per share requirement, but this is a listing compliance issue and not an ethics-related regulatory fine as defined by the rubric.
1
Kind to Animals
-70
The company completed animal testing for its RF and ablation technologies, including an animal safety study using a porcine multi-arterial model.
1
No specific animal testing policy is mentioned across the provided articles, nor is there any indication of the company employing non-animal testing methods for product safety and efficacy.
No War, No Weapons
0
Autonomix Medical, Inc. is a medical device company focused on developing minimally invasive surgical tools and technologies for medical applications. The company's technology, including nerve mapping and ablation, is designed to treat conditions such as cancerous tumors, chronic pain, hypertension, and other metabolic and neurological disorders.
1
There is no evidence of the company deriving revenue from arms or defense contracts, nor is there any indication of its technology having military applications.
2
The company is not involved in any defense-related business, nor does it develop or sell dual-use products with military applications.
3
There is no evidence of sales to embargoed or sanctioned regimes; a clinical trial site in Uzbekistan is mentioned, but this is not a sale to an embargoed regime.
4
There is no information regarding investment in peace technology versus total R&D spending.
5
Planet-Friendly Business
0
No evidence available to assess Autonomix Medical, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to 'Respect for Cultures & Communities'. explicitly states that sustainability data is not available for AMIX.US,
1
and Articles and focus on the company's technology and clinical trials, not on community engagement or cultural impact.
2
Safe & Smart Tech
0
No evidence available to assess Autonomix Medical, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No information was found in the provided articles regarding Autonomix Medical, Inc.'s performance or initiatives related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1